“Cardiovascular Adverse Event Risk in Rheumatoid Arthritis Patients Treated with JAK Inhibitor Tofacitinib versus TNF Inhibitors: a Systematic Review, Meta Analysis, and Meta Regression” (2025) JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, p. 4. doi:10.53366/jimki.vi.949.